Golper T A, Noonan H M, Elzinga L, Gilbert D, Brummett R, Anderson J L, Bennett W M
Division of Nephrology and Hypertension, Oregon Health Sciences University, Portland 97201.
Clin Pharmacol Ther. 1988 May;43(5):565-70. doi: 10.1038/clpt.1988.74.
The renal handling of vancomycin is unknown. Previously reported studies have not achieved steady-state conditions with constant vancomycin concentrations. We measured systemic vancomycin clearance simultaneously with the renal clearances of vancomycin, creatinine, inulin, and para-aminohippurate in nine healthy subjects at steady-state serum vancomycin concentrations of 7 and 14 mg/L. For all steady-state observations the renal clearance of vancomycin was 89 +/- 11 ml/min (mean +/- SE), the clearance of inulin 105 +/- 9 ml/min, the clearance of creatinine 117 +/- 9 ml/min, and the clearance of para-aminohippuric acid 496 +/- 41 ml/min. The systemic clearance of vancomycin was 131 +/- 7 ml/min. The clearances of creatinine, inulin, and para-aminohippuric acid and the renal clearance of vancomycin were not statistically different at both steady-state vancomycin concentrations. The ratio of the renal clearance of vancomycin to the clearance of inulin was 0.89 +/- 0.06 and to creatinine clearance 0.79 +/- 0.05. Both ratios were independent of vancomycin concentration, urine flow rate, and filtration fraction. The systemic clearance of vancomycin was 10% greater at serum vancomycin concentrations of 14 mg/L than at 7 mg/L (p less than 0.05) because of an increase in the nonrenal clearance. Therefore in healthy subjects, 30% of the systemic vancomycin clearance is by nonrenal mechanisms and this nonrenal clearance is concentration dependent. Assuming protein binding to be between 10% and 20%, renal vancomycin excretion is predominantly by glomerular filtration. Small amounts of tubular vancomycin transport cannot be excluded by these techniques.
万古霉素的肾脏处理情况尚不清楚。先前报道的研究未能在万古霉素浓度恒定的情况下达到稳态。我们在9名健康受试者中,当血清万古霉素稳态浓度分别为7 mg/L和14 mg/L时,同时测量了全身万古霉素清除率以及万古霉素、肌酐、菊粉和对氨基马尿酸的肾脏清除率。对于所有稳态观察结果,万古霉素的肾脏清除率为89±11 ml/min(均值±标准误),菊粉清除率为105±9 ml/min,肌酐清除率为117±9 ml/min,对氨基马尿酸清除率为496±41 ml/min。万古霉素的全身清除率为131±7 ml/min。在两种万古霉素稳态浓度下,肌酐、菊粉和对氨基马尿酸的清除率以及万古霉素的肾脏清除率在统计学上无差异。万古霉素肾脏清除率与菊粉清除率的比值为0.89±0.06,与肌酐清除率的比值为0.79±0.05。这两个比值均与万古霉素浓度、尿流率和滤过分数无关。由于非肾脏清除率增加,血清万古霉素浓度为14 mg/L时的万古霉素全身清除率比7 mg/L时高10%(p<0.05)。因此,在健康受试者中,30%的全身万古霉素清除是通过非肾脏机制进行的,且这种非肾脏清除率与浓度有关。假设蛋白结合率在10%至20%之间,万古霉素的肾脏排泄主要通过肾小球滤过。这些技术不能排除少量肾小管对万古霉素的转运。